Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 11, 2019

SELL
N/A
-159,924 Closed
0 $0
Q4 2018

Feb 05, 2019

SELL
N/A
-113,669 Reduced 41.55%
159,924 $1.37 Million
Q3 2018

Oct 03, 2018

SELL
N/A
-54,600 Reduced 16.64%
273,593 $5.48 Million
Q2 2018

Jul 20, 2018

BUY
N/A
118,549 Added 56.55%
328,193 $8.48 Million
Q1 2018

Apr 11, 2018

SELL
N/A
-483,269 Reduced 69.74%
209,644 $5.01 Million
Q4 2017

Jan 19, 2018

SELL
N/A
-222,087 Reduced 24.27%
692,913 $23.5 Million
Q3 2017

Oct 13, 2017

BUY
N/A
915,000
915,000 $19.4 Million

About Adamas Pharmaceuticals, Inc.


  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.